-
Something wrong with this record ?
Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease
O. Pozler, J. Chládek, J. Malý, M. Hroch, P. Dědek, M. Beránek, P. Krásničanová
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Azathioprine metabolism pharmacokinetics therapeutic use MeSH
- Child MeSH
- Genotype MeSH
- Guanine Nucleotides blood pharmacokinetics MeSH
- Inflammatory Bowel Diseases drug therapy enzymology MeSH
- Immunosuppressive Agents metabolism pharmacokinetics therapeutic use MeSH
- Humans MeSH
- Mercaptopurine analogs & derivatives blood metabolism pharmacokinetics MeSH
- Methyltransferases genetics metabolism MeSH
- Adolescent MeSH
- Child, Preschool MeSH
- Prospective Studies MeSH
- Severity of Illness Index MeSH
- Thionucleotides blood pharmacokinetics MeSH
- Treatment Outcome MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND AND AIM: Azathioprine (AZA) has a slow onset of action in treatment of pediatric inflammatory bowel disease (IBD). It is anticipated, that this delay correlates to the kinetics of 6-thioguanine nucleotides (6-TGN) accumulation. The aim of this study was to evaluate the time to steady state of 6-TGN concentration in red blood cells. METHODS: The inclusion criteria were: a) age 0-19 years b) IBD diagnosis c) AZA treatment initiation. High performance liquid chromatography was used for the 6-TGN analysis. Concentrations of metabolites were studied in weeks 0, 1, 2, 5, and 8 after beginning of treatment. RESULTS: The inclusion criteria were matched to 18 patients with IBD. The median time to steady state of 6-TGN was 55.3 days. The mean 6-TGN concentration at the steady state achieved 326 (SD 154) pmol/8.108 erythrocytes. High erythrocyte TPMT activity corresponds to the low steady state 6-TGN concentration and vice versa. This correlation reached statistical significance (p<0.01) for the dose expressed in mg per square meter of body surface area. CONCLUSION: The time to steady state of 6-TGN erythrocyte concentration is significantly shorter than would expected according to clinical observation describe earlier.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027254
- 003
- CZ-PrNML
- 005
- 20160324174241.0
- 007
- ta
- 008
- 120816s2010 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.crohns.2010.06.005 $2 doi
- 035 __
- $a (PubMed)21122571
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Pozler, Oldřich, $u Dept. of Pediatrics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic. pozler@lfhk.cuni.cz $d 1950-2013 $7 jn20000402043
- 245 10
- $a Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease / $c O. Pozler, J. Chládek, J. Malý, M. Hroch, P. Dědek, M. Beránek, P. Krásničanová
- 520 9_
- $a BACKGROUND AND AIM: Azathioprine (AZA) has a slow onset of action in treatment of pediatric inflammatory bowel disease (IBD). It is anticipated, that this delay correlates to the kinetics of 6-thioguanine nucleotides (6-TGN) accumulation. The aim of this study was to evaluate the time to steady state of 6-TGN concentration in red blood cells. METHODS: The inclusion criteria were: a) age 0-19 years b) IBD diagnosis c) AZA treatment initiation. High performance liquid chromatography was used for the 6-TGN analysis. Concentrations of metabolites were studied in weeks 0, 1, 2, 5, and 8 after beginning of treatment. RESULTS: The inclusion criteria were matched to 18 patients with IBD. The median time to steady state of 6-TGN was 55.3 days. The mean 6-TGN concentration at the steady state achieved 326 (SD 154) pmol/8.108 erythrocytes. High erythrocyte TPMT activity corresponds to the low steady state 6-TGN concentration and vice versa. This correlation reached statistical significance (p<0.01) for the dose expressed in mg per square meter of body surface area. CONCLUSION: The time to steady state of 6-TGN erythrocyte concentration is significantly shorter than would expected according to clinical observation describe earlier.
- 650 _2
- $a merkaptopurin $x analogy a deriváty $x krev $x metabolismus $x farmakokinetika $7 D015122
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a azathioprin $x metabolismus $x farmakokinetika $x terapeutické užití $7 D001379
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a guaninnukleotidy $x krev $x farmakokinetika $7 D006150
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunosupresiva $x metabolismus $x farmakokinetika $x terapeutické užití $7 D007166
- 650 _2
- $a idiopatické střevní záněty $x farmakoterapie $x enzymologie $7 D015212
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methyltransferasy $x genetika $x metabolismus $7 D008780
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a thionukleotidy $x krev $x farmakokinetika $7 D013873
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Chládek, Jaroslav, $d 1962- $7 xx0057856 $u Dept. of Pharmacology, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic
- 700 1_
- $a Malý, Jan $7 xx0140436 $u Dept. of Pediatrics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic
- 700 1_
- $a Hroch, Miloš, $d 1976- $7 xx0076212 $u Dept. of Pharmacology, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic
- 700 1_
- $a Dědek, Petr, $d 1965- $7 jn20000400603 $u Dept. of Pediatrics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic
- 700 1_
- $a Beránek, Martin, $d 1968- $7 xx0044204 $u nstitute of Clinical Biochemistry and Diagnostics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic
- 700 1_
- $a Krásničanová, P. $7 _AN025239 $u Dept. of Pediatrics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic
- 773 0_
- $w MED00166945 $t Journal of Crohn's & colitis $x 1876-4479 $g Roč. 4, č. 6 (2010), s. 623-628
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21122571 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20160324174002 $b ABA008
- 999 __
- $a ok $b bmc $g 949296 $s 784600
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 4 $c 6 $d 623-628 $e 20100824 $i 1876-4479 $m Journal of Crohn's and colitis $n J Crohns Colitis $x MED00166945
- LZP __
- $b NLK112 $a Pubmed-20120816/11/02
